Physician profile
George M Babikian
NPI 1972502052
$446,029.42
in general payments reported to CMS, 2019-2025
4 companies · $136K in 2025
The $136K reported for 2025 was more than what 97% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $12K · 2021: $58K · 2022: $86K · 2023: $48K · 2024: $84K · 2025: $136K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $245K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Travel and Lodging: $4,643 · Consulting Fee: $2,244 · Food and Beverage: $1,596 · Education: $86.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $245,024.46 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,087.50 |
| Travel and Lodging | $4,643.49 |
| Consulting Fee | $2,243.75 |
| Food and Beverage | $1,596.11 |
| Education | $86.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $444,572.28 | 2019-2025 | Evos, Anthology, Journey II |
| Zimmer Biomet Holdings, INC. | $741.95 | 2019-2025 | Persona, G7, Avenir |
| Osteocentric Technologies, INC. | $691.19 | 2024-2025 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Arthrex, INC. | $24.00 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Babikian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.